Myasthenia Gravis market size
Jun 28, 2019
Myasthenia gravis Market Outlook
Myasthenia gravis (MG) is an autoimmune syndrome that causes weakness in the skeletal muscles caused due to the failure of neuromuscular transmission. Communication between nerve cells and muscles becomes hampered, thus preventing crucial muscles from contracting. This impairment in results from the binding of auto...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
